accuray research
  • Home
  • /
  • Packaging
  • /
  • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis & Trends - Industry Forecast to 2028

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis & Trends - Industry Forecast to 2028

Share
  • Description
  • Table of Content
  • Request Sample

The Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing includeincreasing focus on pre-clinical development services in contract manufacturing organization (CMO), rising healthcare standards in developing countries and expensive breakthrough therapies and increasing number of small & medium sized companies with CDMO facilities. Based on type, the market is bifurcated into contract manufacturing organization (CMO) and contract research organization (CRO). The contract manufacturing organization (CMO) segment is further sub-segmented into active pharmaceutical (API) and finished dosage formulations (FDF). Active pharmaceutical (API) is sub divided into branded API manufacturing and generic API manufacturing. Finished dosage formulations (FDF) further sub-segmented called oral liquids. Contract research organization (CRO) segment is further divided into clinical trial, data management services, consulting services, laboratory services. On the basis of research phase, the market is classified intophase I, phase II, phase III, phase IV, and pre-clinical. On the contrary to the category, the market is segmented into pharmaceutical industry and biopharmaceutical industry. By therapeutic application, the market is fragmented into pulmonary disorders, infectious diseases, metabolic disorders, cardiovascular disorders, central nervous system, oncology and gastrointestinal disorders. Based on service type, the market is bifurcated into pharmaceutical manufacturing services, biologics manufacturing services and drug development services. Pharmaceutical manufacturing services are segregated into secondary packaging, pharmaceutical finished dosage formulation (FDF) development and manufacturing, and pharmaceutical active pharmaceutical ingredient (API) manufacturing. Pharmaceutical finished dosage formulation (FDF) development and manufacturing is divided into liquid dose formulation, capsule manufacturing services, parenteral/injectable dose formulation, tablet manufacturing services and solid dose formulation. Biologics manufacturing services is further categorized into biologics active pharmaceutical ingredient (API) manufacturing and biologics finished dosage formulation (FDF) manufacturing. Based on end user, the market is divided into academic institutes, medical device companies,generic pharmaceutical and biopharmaceutical companies, big pharma, and small & mid-size pharma. This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2028. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures. This report provides data tables, includes charts and graphs for visual analysis. Regional Analysis: North America - US - Canada - Mexico Europe - France - Germany - Italy - Spain - UK - Rest of Europe Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia Pacific Middle East - Saudi Arabia - UAE - Rest of Middle East Latin America - Argentina - Brazil - Rest of Latin America Rest of the World - South Africa - Others Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2028, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2028 - Market opportunities and recommendations for new investments

1 Market Outline 1.1 Research Methodology 1.1.1 Research Approach & Sources 1.2 Market Trends 1.3 Regulatory Factors 1.4 End User Analysis 1.5 Strategic Benchmarking 1.6 Opportunity Analysis 2 Executive Summary 3 Market Overview 3.1 Current Trends 3.1.1 Increasing Focus on Pre-clinical Development Services in Contract Manufacturing Organization (CMO) 3.1.2 Rising Healthcare Standards in Developing Countries and Expensive Breakthrough Therapies 3.1.3 Increasing Number of Small & Medium Sized Companies with CDMO facilities 3.1.4 Growth Opportunities/Investment Opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 3.4.1 Bargaining power of suppliers 3.4.2 Bargaining power of buyers 3.4.3 Threat of substitutes 3.4.4 Threat of new entrants 3.4.5 Competitive rivalry 4 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Type 4.1 Contract Manufacturing Organization (CMO) DATA TABLE Contract Manufacturing Organization (CMO) Market Forecast to 2028 (US$ MN) 4.1.1 Active Pharmaceutical (API) DATA TABLE Active Pharmaceutical (API) Market Forecast to 2028 (US$ MN) 4.1.1.1 Branded API Manufacturing 4.1.1.2 Generic API Manufacturing 4.1.2 Finished Dosage Formulations (FDF) DATA TABLE Finished Dosage Formulations (FDF) Market Forecast to 2028 (US$ MN) 4.1.2.1 Oral Liquids 4.2 Contract Research Organization (CRO) DATA TABLE Contract Research Organization (CRO) Market Forecast to 2028 (US$ MN) 4.2.1 Clinical Trial DATA TABLE Clinical Trial Market Forecast to 2028 (US$ MN) 4.2.2 Data Management Services DATA TABLE Data Management Services Market Forecast to 2028 (US$ MN) 4.2.3 Consulting Services DATA TABLE Consulting Services Market Forecast to 2028 (US$ MN) 4.2.4 Laboratory Services DATA TABLE Laboratory Services Market Forecast to 2028 (US$ MN) 5 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Research Phase 5.1 Phase I DATA TABLE Phase I Market Forecast to 2028 (US$ MN) 5.2 Phase II DATA TABLE Phase II Market Forecast to 2028 (US$ MN) 5.3 Phase III DATA TABLE Phase III Market Forecast to 2028 (US$ MN) 5.4 Phase IV DATA TABLE Phase IV Market Forecast to 2028 (US$ MN) 5.5 Pre-Clinical DATA TABLE Pre-Clinical Market Forecast to 2028 (US$ MN) 6 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Category 6.1 Pharmaceutical Industry DATA TABLE Pharmaceutical Industry Market Forecast to 2028 (US$ MN) 6.2 Biopharmaceutical Industry DATA TABLE Biopharmaceutical Industry Market Forecast to 2028 (US$ MN) 7 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Therapeutic Application 7.1 •Pulmonary Disorders DATA TABLE •Pulmonary Disorders Market Forecast to 2028 (US$ MN) 7.2 Infectious Diseases DATA TABLE Infectious Diseases Market Forecast to 2028 (US$ MN) 7.3 •Metabolic Disorders DATA TABLE •Metabolic Disorders Market Forecast to 2028 (US$ MN) 7.4 •Cardiovascular Disorders DATA TABLE •Cardiovascular Disorders Market Forecast to 2028 (US$ MN) 7.5 •Central Nervous System DATA TABLE •Central Nervous System Market Forecast to 2028 (US$ MN) 7.6 •Oncology DATA TABLE •Oncology Market Forecast to 2028 (US$ MN) 7.7 •Gastrointestinal Disorders DATA TABLE •Gastrointestinal Disorders Market Forecast to 2028 (US$ MN) 8 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Service Type 8.1 Pharmaceutical Manufacturing Services DATA TABLE Pharmaceutical Manufacturing Services Market Forecast to 2028 (US$ MN) 8.1.1 Secondary Packaging DATA TABLE Secondary Packaging Market Forecast to 2028 (US$ MN) 8.1.2 Pharmaceutical Finished Dosage Formulation (FDF) Development and Manufacturing DATA TABLE Pharmaceutical Finished Dosage Formulation (FDF) Development and Manufacturing Market Forecast to 2028 (US$ MN) 8.1.2.1 Liquid Dose Formulation 8.1.2.2 Capsule Manufacturing Services 8.1.2.3 Parenteral/Injectable Dose Formulation 8.1.2.4 Tablet Manufacturing Services 8.1.2.5 Solid Dose Formulation 8.1.3 Pharmaceutical Active Pharmaceutical Ingredient (API) Manufacturing DATA TABLE Pharmaceutical Active Pharmaceutical Ingredient (API) Manufacturing Market Forecast to 2028 (US$ MN) 8.2 Biologics Manufacturing Services DATA TABLE Biologics Manufacturing Services Market Forecast to 2028 (US$ MN) 8.2.1 Biologics Active Pharmaceutical Ingredient (API) Manufacturing DATA TABLE Biologics Active Pharmaceutical Ingredient (API) Manufacturing Market Forecast to 2028 (US$ MN) 8.2.2 Biologics Finished Dosage Formulation (FDF) Manufacturing DATA TABLE Biologics Finished Dosage Formulation (FDF) Manufacturing Market Forecast to 2028 (US$ MN) 8.3 Drug Development Services DATA TABLE Drug Development Services Market Forecast to 2028 (US$ MN) 9 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By End User 9.1 Academic Institutes DATA TABLE Academic Institutes Market Forecast to 2028 (US$ MN) 9.2 Medical Device Companies DATA TABLE Medical Device Companies Market Forecast to 2028 (US$ MN) 9.3 Generic Pharmaceutical and Biopharmaceutical Companies DATA TABLE Generic Pharmaceutical and Biopharmaceutical Companies Market Forecast to 2028 (US$ MN) 9.4 Big Pharma DATA TABLE Big Pharma Market Forecast to 2028 (US$ MN) 9.5 Small & Mid-Size Pharma DATA TABLE Small & Mid-Size Pharma Market Forecast to 2028 (US$ MN) 10 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Geography 10.1 North America DATA TABLE North America Market Forecast by Countries to 2028 (US$ MN) 10.1.1 US 10.1.2 Canada 10.1.3 Mexico 10.2 Europe DATA TABLE Europe Market Forecast by Countries to 2028 (US$ MN) 10.2.1 Germany 10.2.2 U.K 10.2.3 Italy 10.2.4 France 10.2.5 Spain 10.2.6 Rest of Europe 10.3 Asia Pacific DATA TABLE Asia Pacific Market Forecast by Countries to 2028 (US$ MN) 10.3.1 China 10.3.2 Japan 10.3.3 India 10.3.4 Australia 10.3.5 New Zealand 10.3.6 Rest of Asia Pacific 10.4 Middle East DATA TABLE Middle East Market Forecast by Countries to 2028 (US$ MN) 10.4.1 Saudi Arabia 10.4.2 UAE 10.4.3 Rest of Middle East 10.5 Latin America DATA TABLE Latin America Market Forecast by Countries to 2028 (US$ MN) 10.5.1 Argentina 10.5.2 Brazil 10.5.3 Rest of Latin America 10.6 Rest of the World (RoW) DATA TABLE Rest of the World (RoW) Market Forecast by Countries to 2028 (US$ MN) 10.6.1 South Africa 10.6.2 Others 11 Key Player Activities 11.1 Acquisitions & Mergers 11.2 Agreements, Partnerships, Collaborations and Joint Ventures 11.3 Product Launch & Expansions 11.4 Other Activities 12 Leading Companies 12.1 Aenova Holding GmbH 12.2 Baxter Biopharma Solutions 12.3 Catalent Inc. 12.4 Covance Inc. 12.5 Hangzhou Tigermed Consulting Co Ltd. 12.6 Jubilant Life Sciences Ltd. 12.7 Lonza Group 12.8 Novotech Pty Ltd. 12.9 PAREXEL International Corporation 12.10 Patheon Inc. 12.11 Pfizer CentreSource 12.12 Pharmaceutical Product Development LLC 12.13 PRA Health Sciences Inc. 12.14 Quanticate Ltd. 12.15 Vetter Pharma International GmbH 12.16 WuXi AppTec Inc. List of Tables Table 1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Region, Market Forecast (2016-2028) (US $MN) Table 2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Type, Market Forecast (2016-2028) (US $MN) Table 3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Contract Manufacturing Organization (CMO), Market Forecast (2016-2028) (US $MN) Table 4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Active Pharmaceutical (API), Market Forecast (2016-2028) (US $MN) Table 5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Finished Dosage Formulations (FDF), Market Forecast (2016-2028) (US $MN) Table 6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Contract Research Organization (CRO), Market Forecast (2016-2028) (US $MN) Table 7 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Clinical Trial, Market Forecast (2016-2028) (US $MN) Table 8 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Data Management Services, Market Forecast (2016-2028) (US $MN) Table 9 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Consulting Services, Market Forecast (2016-2028) (US $MN) Table 10 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Laboratory Services, Market Forecast (2016-2028) (US $MN) Table 11 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Research Phase, Market Forecast (2016-2028) (US $MN) Table 12 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Phase I, Market Forecast (2016-2028) (US $MN) Table 13 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Phase II, Market Forecast (2016-2028) (US $MN) Table 14 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Phase III, Market Forecast (2016-2028) (US $MN) Table 15 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Phase IV, Market Forecast (2016-2028) (US $MN) Table 19 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Pre-Clinical, Market Forecast (2016-2028) (US $MN) Table 20 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Category, Market Forecast (2016-2028) (US $MN) Table 21 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Pharmaceutical Industry, Market Forecast (2016-2028) (US $MN) Table 22 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Biopharmaceutical Industry, Market Forecast (2016-2028) (US $MN) Table 23 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Therapeutic Application, Market Forecast (2016-2028) (US $MN) Table 24 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By •Pulmonary Disorders, Market Forecast (2016-2028) (US $MN) Table 25 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Infectious Diseases, Market Forecast (2016-2028) (US $MN) Table 26 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By •Metabolic Disorders, Market Forecast (2016-2028) (US $MN) Table 27 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By •Cardiovascular Disorders, Market Forecast (2016-2028) (US $MN) Table 28 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By •Central Nervous System, Market Forecast (2016-2028) (US $MN) Table 29 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By •Oncology, Market Forecast (2016-2028) (US $MN) Table 30 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By •Gastrointestinal Disorders, Market Forecast (2016-2028) (US $MN) Table 31 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Service Type, Market Forecast (2016-2028) (US $MN) Table 32 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Pharmaceutical Manufacturing Services, Market Forecast (2016-2028) (US $MN) Table 33 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Secondary Packaging, Market Forecast (2016-2028) (US $MN) Table 34 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Pharmaceutical Finished Dosage Formulation (FDF) Development and Manufacturing, Market Forecast (2016-2028) (US $MN) Table 35 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Pharmaceutical Active Pharmaceutical Ingredient (API) Manufacturing, Market Forecast (2016-2028) (US $MN) Table 36 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Biologics Manufacturing Services, Market Forecast (2016-2028) (US $MN) Table 37 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Biologics Active Pharmaceutical Ingredient (API) Manufacturing, Market Forecast (2016-2028) (US $MN) Table 38 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Biologics Finished Dosage Formulation (FDF) Manufacturing, Market Forecast (2016-2028) (US $MN) Table 39 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Drug Development Services, Market Forecast (2016-2028) (US $MN) Table 40 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By End User, Market Forecast (2016-2028) (US $MN) Table 41 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Academic Institutes, Market Forecast (2016-2028) (US $MN) Table 42 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Medical Device Companies, Market Forecast (2016-2028) (US $MN) Table 43 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Generic Pharmaceutical and Biopharmaceutical Companies, Market Forecast (2016-2028) (US $MN) Table 44 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Big Pharma, Market Forecast (2016-2028) (US $MN) Table 45 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market By Small & Mid-Size Pharma, Market Forecast (2016-2028) (US $MN) NOTE: Tables for North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the World are represented in the same manner above.

Speak to Analyst

Request for Discount

Need a Customized Report

Request Sample

clicking on ".ar__close" removes class "open" on ".ar__modal" clicking on ".search_btn" toggles class "open" on "#search_md" clicking on "#category_dd_btn" toggles class "open" on "#category_dd" clicking on ".dp__backdrop" removes class "open" on "#category_dd" clicking on "#category_dd__md_btn" toggles class "open" on "#category_dd_mb" clicking on ".dp__backdrop" removes class "open" on "#category_dd_mb" clicking on ".nav__dp" toggles class "hidden" on "#nav_menu" clicking on ".dp__md_backdrop" removes class "open" on ".ar__modal" clicking on ".analyst_btn" adds class "open" on "#analyst_md" clicking on ".discount_btn" adds class "open" on "#discount_md" clicking on ".customization_btn" adds class "open" on "#customization_md" clicking on ".sample_btn" adds class "open" on "#sample_md" clicking on ".tab-btn" removes class "active" on ".tab-btn.active" clicking on ".tab-btn" removes class "active" on ".tab-context.active" clicking on ".tab-btn" adds class "active" on "target" clicking on "#tab1" adds class "active" on "#tab-wn1" clicking on "#tab2" adds class "active" on "#tab-wn2" clicking on "#tab3" adds class "active" on "#tab-wn3"